Cargando…

Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine

Syndecan-1 (SDC1, CD138) is a key cell surface adhesion molecule essential for maintaining cell morphology and interaction with the surrounding microenvironment. Deregulation of SDC1 contributes to cancer progression by promoting cell proliferation, metastasis, invasion and angiogenesis, and is asso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akl, Mohamed R., Nagpal, Poonam, Ayoub, Nehad M., Prabhu, Sathyen A., Gliksman, Matthew, Tai, Betty, Hatipoglu, Ahmet, Goy, Andre, Suh, K. Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745686/ https://www.ncbi.nlm.nih.gov/pubmed/26293675

Ejemplares similares

Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies
por: Akl, Mohamed R., et al.
Publicado: (2016)

Pediatric Hodgkin lymphoma– biomarkers, drugs, and clinical trials for translational science and medicine
por: Nagpal, Poonam, et al.
Publicado: (2016)

Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine
por: Lodhi, Niraj, et al.
Publicado: (2020)

Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents
por: Inamdar, Arati A., et al.
Publicado: (2016)

Editorial: Novel Combination Therapies for the Treatment of Solid Cancers
por: Ayoub, Nehad M.
Publicado: (2021)

Syndecan-1 (sCD138) levels in chronic lymphocytic leukemia: clinical and hematological correlations
por: Sharma, Monica, et al.
Publicado: (2018)

Syndecan-3 and syndecan-4 are enriched in Schwann cell perinodal processes
por: Goutebroze, Laurence, et al.
Publicado: (2003)

The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma
por: Prabhu, Sathyen A., et al.
Publicado: (2020)

High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma
por: Zhu, Yufei, et al.
Publicado: (2022)

Syndecan-Regulated Receptor Signaling
por: Rapraeger, Alan C.
Publicado: (2000)

Syndecan-3 gets the message
por: Leslie, Mitch
Publicado: (2011)

The Cardiac Syndecan-2 Interactome
por: Mathiesen, Sabrina Bech, et al.
Publicado: (2020)

Syndecan-3 in Inflammation and Angiogenesis
por: Arokiasamy, Samantha, et al.
Publicado: (2020)

Syndecans in Inflammation at a Glance
por: Gopal, Sandeep
Publicado: (2020)

Syndecan-1 in Liver Diseases
por: Regős, Eszter, et al.
Publicado: (2019)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009)

Syndecan-1 Enhances Proliferation, Migration and Metastasis of HT-1080 Cells in Cooperation with Syndecan-2
por: Péterfia, Bálint, et al.
Publicado: (2012)

Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors
por: Albitar, Maher, et al.
Publicado: (2023)

Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis
por: Cerbelli, Bruna, et al.
Publicado: (2022)

Evaluation of the factors affecting the prognosis of patients with solid tumors and hematologic malignancies in the intensive care unit
por: Savran, Y, et al.
Publicado: (2015)

The expression of syndecan-1, syndecan-4 and decorin in healthy human breast tissue during the menstrual cycle
por: Hallberg, Gunilla, et al.
Publicado: (2010)

Induced expression of syndecan in healing wounds
Publicado: (1991)

The expression of syndecan-1 in psoriatic epidermis
por: Tomas, Davor, et al.
Publicado: (2008)

Syndecans in tumor cell adhesion and signaling
por: Beauvais, DeannaLee M, et al.
Publicado: (2004)

A syndecan-based tumor stopper
por: Maxmen, Amy
Publicado: (2009)

Shed syndecan-2 inhibits angiogenesis
por: De Rossi, Giulia, et al.
Publicado: (2014)

Regulated Shedding of Syndecan Ectodomains by Chemokines
por: Charnaux, Nathalie, et al.
Publicado: (2006)

Syndecan-4 in Tumor Cell Motility
por: Keller-Pinter, Aniko, et al.
Publicado: (2021)

Baseline serum syndecan-4 predicts prognosis after the onset of acute exacerbation of idiopathic interstitial pneumonia
por: Sato, Yuki, et al.
Publicado: (2017)

Syndecan-1 Is Required to Maintain Intradermal Fat and Prevent Cold Stress
por: Kasza, Ildiko, et al.
Publicado: (2014)

Positive Association of Metabolic Syndrome with a Single Nucleotide Polymorphism of Syndecan-3 (rs2282440) in the Taiwanese Population
por: Chang, Betty Chia-Chen, et al.
Publicado: (2018)

iPad in education for dummies
por: Gliksman, Sam
Publicado: (2015)

iPad in education for dummies
por: Gliksman, Sam
Publicado: (2013)

Molecular cloning of syndecan, an integral membrane proteoglycan
Publicado: (1989)

Syndecan expressions in the human amnion and chorionic plate
por: Lorenzi, T., et al.
Publicado: (2010)

Heparanase Regulates Levels of Syndecan-1 in the Nucleus
por: Chen, Ligong, et al.
Publicado: (2009)

A novel role for syndecan-3 in angiogenesis
por: De Rossi, Giulia, et al.
Publicado: (2013)

Is Syndecan-2 a Key Angiogenic Element?
por: Noguer, Oriol, et al.
Publicado: (2009)

Transmembrane Domain—Dependent Functional Oligomerization of Syndecans
por: Yi, Jae Youn, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_83cngh67599la0cc673sm2df8p